Author Archives: ev1

Caf̩ Scientifique Topic 27: Scientific Construction of Race РVideo

Posted on by


Café Scientifique Topic 27: Scientific Construction of Race
How much do you really know about the geographic, racial and ethnic origins of your personal ancestors? How old were you when you first learned about race? Come join us in a fascinating conversation about the evolution of race and what scientists say about race with Mike Lange, Associate Professor of Anthropology, Champlain College and John Burke, Professor, Microbiology Molecular Genetics, UVM. View the exhibit Race: Are We So Different? during social time.

By: echovermont

Link:
Café Scientifique Topic 27: Scientific Construction of Race - Video

Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry, Genetic …

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pcxchs/middle_east_and) has announced the addition of GlobalData's new report "Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

Our new report, Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Middle East and Africa In Vitro Diagnostics Market - South Africa, Israel and Saudi Arabia.

The report provides value (USD million) data for all the market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Scope

- Countries covered include South Africa, Israel and Saudi Arabia.. - Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. - Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the market categories and countries. - Global corporate-level profiles of key companies operating within the Middle East and Africa In Vitro Diagnostics market.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 In Vitro Diagnostics in Middle East and Africa

Read the original here:
Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic ...

Recent advances in Microbiology – Rapid Mycoplasma Test

Posted on by

SMis Pharmaceutical Microbiology conference taking place on the 30th & 31st January London will provide attendees with an expert and highly accredited speaker line who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.

London (PRWEB UK) 9 January 2013

SMi is pleased to confirm John Duguid, Principle Analytical Scientist, Genzyme as a speaker at the upcoming event. Mr. Duguid is currently responsible for developing, validating, and transferring molecular biology assays for rapid microbiology and cell differentiation application s, managing complex projects to implement process changes, and using statistical process control tools to implement process analytical technology for cell therapy products

He will address the selection, validation and automation of rapid mycoplasma test, looking at how to do a selection using a risk based approach, validation according to PhEur 2.6.7 and automation for routine testing. Attending will enable delegates to hear

Over 13 speakers from top pharma companies that include Sanofi-Aventis, Genzyme, GlaxoSmithKline, Pfizer, Merck and MedImmune

For more information visit http://www.smi-online.co.uk/goto/pharma-microbiology59.asp alternatively contact Cem Tuna on +44 0 207 827 6184 or email on ctuna(at)smi-online(dot)co(dot)uk

Sonal Patel SMi Group Ltd 0207 827 6106 Email Information

Here is the original post:
Recent advances in Microbiology – Rapid Mycoplasma Test

Research and Markets: Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tg7hqs/microbiology) has announced the addition of GlobalData's new report "Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" to their offering.

The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories - Bacterial Identification & Susceptibility Testing, Blood Culture, Mycobacteria Culture, Microbiology Analyzers, Immunological Culture Identification, Parasitology Culture and Mycology Culture.

The report also provides company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

Scope

- Market size data for Microbiology Culture market categories

- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the seven market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.

- 2011 company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Microbiology Culture market in BRICS.

Reasons to Buy

See original here:
Research and Markets: Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Longevity Global Inc Brings a New Range of Welder Machines and Welding Equipment

Posted on by

Offering attractive discounts on welding equipment and welder machines, Longevity Global Inc is fast becoming a one-stop online shop for welding services providers. Thus, catering the requirement for durable and high-end welder equipment for DIY, the company provides user-friendly buying experience i.e. buyers can browse through a range of welding machines and equipment before deciding the right one.

Hayward, Ca (PRWEB) January 11, 2013

Longevity Global Inc is innovative and for decades has been bringing up fine range of welding machines and equipment that are being used in by the companies for welding purposes in large and small scales. The company provides durable and higher performance welder machines to users designed and developed through innovation and that is why it has been able to meet customer satisfaction.

Being a leading production company it also brings welders for sale wherein it sells them at attractively lower prices and provides attractive discounts. Longevity Global Inc is known for offering fine range of welding machines and others for customers in in the countries such as Brazil, Australia, UK, Mexico, Canada wherein it has developed a network of distributors.

It also has a welding forum wherein users can talk and discuss the machines and tools that are of their use. Talking about the feature, a company professional said, With our welding forum you access to view some welding discussions, access to our other features such as contests and giveaways for welding equipment, and lots of member only privileges. He further says that there are limitations for guests; however, there are no restrictions for members.

About the company:

LONGEVITY Global Inc is recognized worldwide for providing reliable welding, and power generating equipment. Since its inception 2001, LONGEVITY has earned the slogan, "The Power to Last" through innovation, customer satisfaction, and industry leading production. Welding, cutting, and power generating equipment from the company have exceptional quality and durability achieved through R &D department. It has no excuse DOA policy, and samples products to the top welders in the United States to receive crucial feedback, which drives innovation.

For more information please visit http://www.longevity-inc.com

Simon Katz Longevity, Inc. 1.877.566.4462 Email Information

Read more from the original source:
Longevity Global Inc Brings a New Range of Welder Machines and Welding Equipment

Biology Labs as Coop Class (Apologia Biology Experiment Module 10.1) – Video

Posted on by


Biology Labs as Coop Class (Apologia Biology Experiment Module 10.1)
This video is meant to give you a taste of what biology labs can be like in a co-op setting. I set up a camera at one end of the room and let it run while we did Experiment 10.1 during Co-op Week 9. It really is necessary for the students to talk as they work in pairs, so it can get a bit noisy. Also, this particular week our classroom was open to the musical rehearsal in the room next to us (the folding wall was broken) so it was a bit more noisy than normal, but the video will still give you a good idea of how labs in a group setting can look.

By: Conniethedaisyhead

Continue reading here:
Biology Labs as Coop Class (Apologia Biology Experiment Module 10.1) - Video

The New v.3.0 Atheism – Video

Posted on by


The New v.3.0 Atheism
Dr. Norman Geisler A 2013 perspective. Microbiologist Michael Behe: "The impotence of Darwinian theory in accounting for the molecular basis of life is evident not only from the analyses in this book, but also from the complete absence in the professional scientific literature of any detailed models by which complex biochemical systems could have been produced, as shown in Chapter 8. In the face of the enormous complexity that modern biochemistry has uncovered in the cell, the scientific community is paralyzed. No one at Harvard University, no one at the National Institutes of Health, no member of the National Acacemy of Sciences, no Nobel prize winner mdash;no one at all can give a detailed account of how the cilium, or vision or blood clotting or any complex biochemical process might have developed in a Darwinian fashion. But we are here. Plants and animals are here. The complex systems are here. All these things got here somehow: if not in a Darwinian fashion, then how?"

By: pbar1000

Read this article:
The New v.3.0 Atheism - Video

Building a Diverse Future for the Biological Sciences – Video

Posted on by


Building a Diverse Future for the Biological Sciences
(Visit: http://www.uctv.tv Panel analyzes the double bind in the biological sciences, assessing the pipeline and the potential for building a more diverse faculty. Moderated by Ram Seshadri, Associate Director of the Materials Research Lab Professor of Materials, Chemistry Biochemistry, UC Santa Barbara. Panelists: Albert Bennett, Dean of School of Biological Sciences Professor, Ecology and Evolutionary Biology, UC Irvine; Diane O #39;Dowd, Department Chair Professor of Developmental and Cell Biology, UC Irvine; Luis Mota-Bravo, Director, Outreach, Research Training and Minority Science Programs, UC Irvine Series: "Building Capacity for Institutional Transformation in the Twenty-First Century: Women of Color in STEM and SBS Fields - UC ADVANCE " [1/2013] [Education] [Show ID: 24625]

By: UCtelevision

View post:
Building a Diverse Future for the Biological Sciences - Video

Artificial “Poop” Cures Gut Superbug C. Difficile

Posted on by

Featured Article Academic Journal Main Category: GastroIntestinal / Gastroenterology Also Included In: Infectious Diseases / Bacteria / Viruses;MRSA / Drug Resistance;Biology / Biochemistry Article Date: 11 Jan 2013 - 9:00 PST

Current ratings for: Artificial "Poop" Cures Gut Superbug C. Difficile

1 (1 votes)

5 (1 votes)

The synthetic stool, called RePOOPulate, is the creation of Emma Allen-Vercoe, a microbiologist at the University of Guelph in Canada.

Allen-Vercoe is also the senior author of a paper describing a study of the artificial "super-probiotic" poop that was published in the first issue of a new online, peer-reviewed science journal Microbiome on Wednesday.

As a consequence, the bacterium overpopulates the gut, producing nasty toxins, when healthy, less resistant, gut bacteria are killed off by antibiotics.

Outbreaks resulting from recurring infections of C. difficile tend to occur where lots of people who are either sick or vulnerable to illness are under one roof, such as in hospitals and residential care homes.

For example, one study, reported at a conference in the US in October 2012, showed how treating patients with donated human stool mixed with water through a nasogastric tube or colonoscopy resulted in a complete and fast recovery with no negative side effects in 43 out of 49 of them.

But Allen-Vercoe says in a press statement, while stool transplants using fecal matter from healthy people is an effective therapy for recurring C. difficile infections, they carry the risk of introducing other unknown pathogens, which potentially "puts people at risk for future disease".

See more here:
Artificial "Poop" Cures Gut Superbug C. Difficile

IP Resources Arranges Licensing Deal for New Stem Cell Skin Care Product on Forbes List of Top 10 Fashion and Beauty …

Posted on by

LOS ANGELES, CA--(Marketwire - Jan 10, 2013) - Hanover Portfolio Acquisitions ( OTCQB : HVPA ) and its wholly owned subsidiary IP Resources International, an intellectual property licensing and commercialization company, announced today that it has concluded an international commercialization and licensing agreement with Personal Cell Sciences Corp., the developer of U Autologous, a skin care suite that uses a person's own stem cells to create "the world's first skin care line designed and created especially for you."

IP Resources has participated in the development of an exclusive license between Personal Cell Sciences and BALS Holdings Limited for the commercialization and distribution of Personal Cell Sciences' U Autologous skin care line in Hong Kong and Macau. As a result of the transaction, IP Resources is to receive royalty revenues from the distributor's future sales of U Autologous products in Hong Kong and Macau.

U Autologous is a cutting-edge innovative personalized anti-aging skin care line developed by Personal Cell Sciences Corp. The proprietary ingredient Autokine-CM is created through a manufacturing and processing collaboration with American CryoStem Corporation. To create the U-Autologous product, Adipose Tissue (fat) is collected from the customer using American CryoStem's proprietary, CELLECT adipose tissue collection system and processed at American CryoStem's laboratory to create the individual's unique Autokine-CM. Personal Cell Sciences and U Autologous Skin Care were listed on the Forbes Top 10 Fashion and Beauty Startups for 2012 and as the "Biggest Beauty Breakthrough of 2012" by Glamour.com

Hong Kong and Macau are special administrative regions of the People's Republic of China. According to MarketLine, the Asia-Pacific skincare market had total revenues of $41.9 billion in 2011, representing a compound annual growth rate (CAGR) of 4.6% between 2007 and 2011. Market growth is expected to accelerate and to reach $57.8 billion by 2016.

"With Hong Kong and Macau being major luxury shopping destinations for mainland China, one of the largest and fastest growing skin care markets in the world, we believe Personal Cell Sciences' personalized skin care line will gain traction in this thriving market," stated Alan Collier, CEO and Chairman of Hanover Portfolio Acquisitions and IP Resources International. "This licensing transaction is an important milestone and example of IP Resources' ability to execute on its core business of commercializing and monetizing innovative technologies through joint ventures and international licensing agreements."

American CryoStemAmerican CryoStem Corporation is a leading biotech company focused on marketing its clinical processing services and patented products for adipose (fat) tissue and adipose derived adult stem cells. Our clinical tissue processing, patented cell culture media products and tissue storage platform supports cosmetic and regenerative medicine applications being developed globally. The Company provides high quality, clinically processed viable cells, while at the same time developing cutting edge applications, therapies, patented laboratory products and services for consumer and commercial applications.

About Hanover Portfolio Acquisitions & IP Resources InternationalHanover Portfolio Acquisitions, through its wholly owned subsidiary, IP Resources International, is an intellectual property management firm that specializes in the commercialization of compelling technologies through joint ventures and international licensing. The Company specializes in the commercialization of technologies within the healthcare, energy, consumer electronics, and internet industries.

Safe Harbor StatementThis press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

See the original post:
IP Resources Arranges Licensing Deal for New Stem Cell Skin Care Product on Forbes List of Top 10 Fashion and Beauty ...

Jorge Paz MD: Adult Stem Cell Therapy for Arthritis, Sports Injury, and Autoimmune Disease || 3 of 3 – Video

Posted on by


Jorge Paz MD: Adult Stem Cell Therapy for Arthritis, Sports Injury, and Autoimmune Disease || 3 of 3
Stem cell therapy for osteoarthritis using adipose (fat) stem cell. Case study of 76 year-old man with osteoarthritis in his knees. Stromal vasular fraction treatment statistics including side effects collected over 800 infusions. Stem cell treatments for sports injuries and why pro sports stars are seeking treatment. Case study of a professional dancer with knee and neck problems who returned to competition after stem cell treatment in Panama.

By: cellmedicine

Continued here:
Jorge Paz MD: Adult Stem Cell Therapy for Arthritis, Sports Injury, and Autoimmune Disease || 3 of 3 - Video

Physiology Degree Online – Video

Posted on by


Physiology Degree Online
Most online bachelor #39;s degrees in exercise physiology typically allow students to complete coursework at their own pace within a specific time frame for each assignment and class. However, almost all programs will require students to complete a clinical practicum or internship, usually during a student #39;s senior year, before being eligible to graduate. It is also important to earn certification before entering the workforce, as most employers will require instructors to be certified. Most trainers need to be certified in cardiopulmonary resuscitation (CPR) before applying for other certifications. The National Commission for Certifying Agencies (NCCA) lists accredited organizations that offer sports training certification.

By: Bhaskar Banerjee

See the article here:
Physiology Degree Online - Video